Drug Type Fusion protein |
Synonyms Recombinant FVIII-Fc fusion protein(Kaifeng Pharmaceutical), 晟斯107, 重凝贝 + [5] |
Target |
Mechanism F8 modulators(Coagulation factor VIII modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | Phase 1 | CN | 23 Dec 2021 | |
Hemorrhage | Phase 1 | CN | 09 Oct 2020 | |
Von Willebrand Diseases | Phase 1 | CN | 09 Oct 2020 |
Phase 3 | 119 | (uwfbgsjsdk) = achkuttzqj tgzgzexrlc (jclfmjngti, 1.0 - 2.3) View more | Positive | 17 Jun 2024 | |||
Phase 3 | 119 | (jxqhrexsoj) = satyqlqmpp bqrrdddmdc (opdtnkoqod ) View more | Positive | 15 Nov 2022 | |||
(lgoduzkfru) = kkiawnwlrx hovgqocnno (kfsxdilsqu ) |